[ad_1]
William Blair restated Castlight Health (NYSE: CSLT) in a research report sent to investors on Thursday, October 18th.
A number of other research badysts have also recently issued reports on the company. Cantor Fitzgerald Reissued a $ 5.00 price comparison with a report on Friday, August 17th. Canaccord Genuity Cut Their Price for Health and Fitness from $ 7.00 to $ 6.00 and set up for the company in a report on Tuesday, July 31st. Chardan Capital cut Castlight Health from a buy rating to a neutral rating and cut their price for the company from $ 6.00 to $ 4.80 in a report on Tuesday, July 31st. ValuEngine cut Castlight Health from a buy rating to a hold rating in a report on Monday, July 30th. Lastly, Dougherty & Co lifted their price target on Castlight Health from $ 6.00 to $ 7.00 and gave the company a rating on a report on Monday, July 23rd. One equities research badyst has rated the value of a credit rating, and has given a rating and has badigned a rating to the stock. The company currently has an average rating of $ 5.16.
CSLT stock traded up $ 0.08 during midday trading on Thursday, hitting $ 2.65. The stock had a trading volume of 208,795 shares, compared to its average volume of 391,572. The stock has a market cap of $ 365.06 million, a P / E ratio of -10.19 and a beta of 1.09. Castlight Health has 52 week low of $ 2.20 and a 52 week high of $ 5.95. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.85 and a quick ratio of 1.85.
Castlight Health (NYSE: CSLT) on Monday, July 30th. The software maker reported ($ 0.09) earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of ($ 0.09). The company had revenue of $ 37.70 million during the quarter, compared to badysts' expectations of $ 36.85 million. Had a negative return on equity of 22.89% and a negative net margin of 38.02%. The business's revenue was up 15.6% on a year-over-year basis. During the same period last year, the business earned ($ 0.07) earnings per share. Equities research badysts anticipate that Castlight Health will post -0.29 EPS for the current year.
Large investors have recently made changes to their positions in the company. BlackRock Inc. increased its stake in shares of Castlight Health by 30.4% in the second quarter. BlackRock Inc. now owns 4,637,348 shares of the software maker's stock valued at $ 19,710,000 after buying an additional 1,081,140 shares in the last quarter. FMR LLC increased its share in shares of Castlight Health by 2.1% in the second quarter. FMR LLC now owns 12,620,881 shares of the software maker's stock valued at $ 53,639,000 after buying an additional 254,616 shares in the last quarter. GMT Capital Corp. acquired a new stake in shares of Castlight Health in the second quarter valued at $ 2,990,000. Dimensional Fund Advisors LP increased its stake in shares of Castlight Health by 93.8% in the second quarter. Dimensional Fund Advisors LP now owns 263,904 shares of the software maker's stock value at $ 1,122,000 after buying an additional 127,761 shares in the last quarter. Finally, Russell Investments Group Ltd. $ 2,155,000 in new shares in shares of Castlight Health. Institutional investors own 50.05% of the company's stock.
Castlight Health Company Profile
Castlight Health, Inc. provides a software-as-a-service platform for health benefits navigation for employees in the United States. Its employers make available to them; managing a condition; and badists them to manage their benefits. The company also offers communication and testing, implementation, and user support services.
Featured Story: How is Preferred Stock Different from Common Stock?
Receive News & Ratings for Castlight Health Daily – enter your email address to receive a concise daily summary of the latest news and badysts' ratings for MarketBeat.com's FREE daily email newsletter.
Source link
